Latest News and Press Releases
Want to stay updated on the latest news?
-
- Pre-Investigational New Drug (“IND”) meeting with the FDA expected to be held in calendar 2020 - Submit first IND in calendar 2021 SAN DIEGO, May 22, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings,...
-
SAN DIEGO, May 17, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Wednesday, May 22, 2019 at 5:00 p.m. Eastern Time (ET) to discuss the...
-
SAN DIEGO, April 17, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a...
-
SAN DIEGO, March 14, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that it will participate in a panel at the 31st Annual ROTH Conference, being held...
-
SAN DIEGO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
-
Pre-Investigational New Drug (“IND”) meeting with the FDA expected to be held in calendar 2019Submit first IND in calendar 2020 SAN DIEGO, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc....
-
SAN DIEGO, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, February 7, 2019 at 5:00 p.m. Eastern Time (ET) to discuss...
-
SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
-
November 12, 2018 08:05 ET | Source: Organovo, Inc.; International Institute for the Advancement of Medicine (“IIAM”)
SAN DIEGO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
-
Pre-Investigational New Drug (“IND”) meeting with the FDA expected to be held in calendar 2019Second orphan designation anticipated in first half of calendar 2019Submit first IND in calendar 2020 ...